Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Biliary Tract Cancer × theasinensin A × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Biliary Tract Cancer 1

Interventions

lenvatinib 3 tislelizumab 2 pembrolizumab 2 Gemcitabine 2 Cisplatin 2 toripalimab 1 theasinensin A 1 surufatinib 1 sitravatinib 1 sintilimab 1 durvalumab 1 S 1 (combination) 1 Folfox protocol 1 Fluorouracil 1 Cryosurgery 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04027764 2019-07-22

Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer

Chinese PLA General Hospital

Phase 2 Unknown

Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡